G-inflamm Liquid
NDC Package 55714-4785-1
Package Information
G-inflamm (chamomilla, echinacea, iris versicolor, ruta graveolens, taraxacum officinale, antimonium crudum, argentum nitricum, arsenicum album, baptisia tinctoria, bismuthum metallicum, bryonia, cinchona officinalis, colocynthis, graphites, hepar sulphuris calcareum, hydrastis canadensis, ipecacuanha, kali bichromicum, kali carbonicum, lycopodium clavatum, magnesia carbonica, magnesia phosphorica, nux vomica, phosphorus, podophyllum peltatum, pulsatilla, zingiber officinale.) liquids is formulated for symptoms such as indigestion, nausea, vomiting, and a feeling of fullness in upper abdomen after eating. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-4785.
Identification & Billing
Clinical Specifications
- ANEMONE PULSATILLA 15 [hp_X]/mL
- ANTIMONY TRISULFIDE 15 [hp_X]/mL
- ARSENIC TRIOXIDE 15 [hp_X]/mL
- BAPTISIA TINCTORIA ROOT 15 [hp_X]/mL
- BISMUTH 15 [hp_X]/mL
- BRYONIA ALBA ROOT 15 [hp_X]/mL
- CALCIUM SULFIDE 15 [hp_X]/mL
- CINCHONA OFFICINALIS BARK 15 [hp_X]/mL
- CITRULLUS COLOCYNTHIS FRUIT PULP 15 [hp_X]/mL
- ECHINACEA, UNSPECIFIED 6 [hp_X]/mL
- GINGER 15 [hp_X]/mL
- GOLDENSEAL 15 [hp_X]/mL
- GRAPHITE 15 [hp_X]/mL
- IPECAC 15 [hp_X]/mL
- IRIS VERSICOLOR ROOT 6 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 15 [hp_X]/mL
- MAGNESIUM CARBONATE 15 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 15 [hp_X]/mL
- MATRICARIA CHAMOMILLA 6 [hp_X]/mL
- PHOSPHORUS 15 [hp_X]/mL
- PODOPHYLLUM 15 [hp_X]/mL
- POTASSIUM CARBONATE 15 [hp_X]/mL
- POTASSIUM DICHROMATE 15 [hp_X]/mL
- RUTA GRAVEOLENS FLOWERING TOP 6 [hp_X]/mL
- SILVER NITRATE 15 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 15 [hp_X]/mL
- TARAXACUM OFFICINALE 6 [hp_X]/mL
- Allergens - [CS]
- Allergens - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Food Additives - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-4785 - G-inflamm
- 55714-4785-1 - 30 mL in 1 BOTTLE, GLASS
- 55714-4785 - G-inflamm
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-4785-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of G-inflamm, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains anemone pulsatilla; antimony trisulfide; arsenic trioxide; baptisia tinctoria root; bismuth; bryonia alba root; calcium sulfide; cinchona officinalis bark; citrullus colocynthis fruit pulp; echinacea, unspecified; ginger; goldenseal; graphite; ipecac; iris versicolor root; lycopodium clavatum spore; magnesium carbonate; magnesium phosphate, dibasic trihydrate; matricaria chamomilla; phosphorus; podophyllum; potassium carbonate; potassium dichromate; ruta graveolens flowering top; silver nitrate; strychnos nux-vomica seed; taraxacum officinale as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on September 02, 2019. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714478501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.